MM&M Weekly Digest is a weekly roundup of the week's big stories and notable developments in healthcare marketing, delivered every Friday.

Latest News

Jobson Medical files for chapter 11 debt relief

Jobson Medical Information Holdings filed for chapter 11 bankruptcy in New York Thursday, the company said, part of an effort to amend and extend its credit and strengthen its balance sheet.
 

Allergan scrubs some doc-payment data, spares med-ed grants

Allergan removed records from its website that had detailed payments made to doctors from the middle of 2010 through first-half 2011.
 

Elsevier begins outreach as push-back on publisher threatens to widen

An online protest, which had more than 2,500 supporters as of Wednesday morning, has pulled the scientific publishing industry into a fight between the publishers and the published.
 

Bydureon approval a shot across bow for Victoza

The FDA's go-ahead for Bydureon gives maker Amylin a much-needed win in the GLP-1 market.
 

FDA study casts doubt on danger of "distracting visuals"

An FDA study looking at the power of background visuals to distract viewers from the often-ominous risk info read in the "major statement" section of TV drug ads found no evidence that consumer understanding of risk info is affected by the "emotional (affective) tone of images.
 

Generics makers approach a cliff of their own

Generic drug sales will peak this year, says a Goldman Sachs report, as the sector approaches its own cliff.
 

AstraZeneca announces more layoffs, Q4 results

AstraZeneca confirmed rumors of another round of deep cuts, announcing that it will eliminate 7,300 positions throughout the company.
 

Ernst & Young's Buck Luce named HBA Woman of the Year

The Healthcare Businesswomen's Association named Ernst & Young global pharma lead Carolyn Buck Luce, calling her "a dedicated leader promoting women's advancement in healthcare."
 

Merck results buoyed by sales of Januvia franchise

Merck said Thursday its ownership of the global marketplace for DPP-IV diabetes drugs helped it close out the quarter with $12.3 billion in sales, and $48 billion in sales for the year. The two drugs behind the boost were Januvia, which saw a 42% bump in fourth quarter sales, and Janumet, which saw sales jump 34% for the quarter.
 

Study outlines how to improve company reputation

An industry reputation study found out that protecting Big Pharma's reputation requires more than a single good deed.
 




HCB is a full-service, healthcare marketing communications agency headquartered in Austin, Texas. Our approach is to outsmart your competition, not outspend them. By simplifying workflows and streamlining processes, we can help you get more out of your next pharmaceutical or medical device launch. It's time to stop throwing money at the problem. Visit us at www.HCBhealth.com.



Advertise
For details on how to advertise in MM&M Weekly Digest, please email Doreen Gates

Unsubscribe
To unsubscribe from the MM&M Weekly Digest click here.
To manage your entire MM&M profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "email.mmm-online.com". When configuring e-mail or spam
filter rules, please use this domain name.

Medical Marketing & Media Magazine
114 W. 26th Street 4th Floor
New York N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150
http://www.mmm-online.com/

© 2013 Haymarket Media Inc.